Is INZY or SCHD a better dividend investment in 2026?

INZY currently yields 50.00% with a 5% 5-year dividend growth rate. SCHD yields 3.44% with 13.05% growth. The better choice depends on your goal: INZY offers higher current income.

What is the dividend yield difference between INZY and SCHD?

INZY has a forward dividend yield of 50.00% ($2.00/share annually). SCHD yields 3.44% ($1.06/share annually). The yield gap is 46.56 percentage points.

Home › Compare › INZY vs SCHD

INZY vs SCHD: Dividend Comparison 2026

INZY yields 50.00% · SCHD yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 INZY wins by $365.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

INZY

● Live price

50.00%

Share price

$4.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$394.0K

Annual income

$79,849.97

Full INZY calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.44%

Share price

$30.68

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$422.61

Full SCHD calculator →

Portfolio growth — INZY vs SCHD

📍 INZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	INZY	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, INZY + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

INZY pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INZY

Annual income on $10K today (after 15% tax)

$4,250.00/yr

After 10yr DRIP, annual income (after tax)

$67,872.47/yr

SCHD

Annual income on $10K today (after 15% tax)

$292.49/yr

After 10yr DRIP, annual income (after tax)

$359.22/yr

At 15% tax rate, INZY beats the other by $67,513.26/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INZY + SCHD for your $10,000?

INZY: 50%SCHD: 50%

100% SCHD50/50100% INZY

Portfolio after 10yr

$211.5K

Annual income

$40,136.28/yr

Blended yield

18.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on INZY right now

INZY

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$12.00

+200.0% upside vs current

Range: $4.00 — $16.00

Altman Z

-6.5

Piotroski

2/9

SCHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INZY buys

SCHD buys

No recent congressional trades found for INZY or SCHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricINZYSCHD

Forward yield	50.00% ✓	3.44%
Annual dividend / share	$2.00 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$394.0K ✓	$29.0K
Annual income after 10y	$79,849.97 ✓	$422.61
Total dividends collected	$314.4K ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: INZY vs SCHD ($10,000, DRIP)

Year	INZY Portfolio	INZY Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$15,700	$5,000.00	$11,224	$344.10	+$4.5K → INZY
2	$24,135	$7,336.45	$12,567	$354.98	+$11.6K → INZY
3	$36,365	$10,540.42	$14,038	$365.30	+$22.3K → INZY
4	$53,753	$14,842.48	$15,648	$375.06	+$38.1K → INZY
5	$78,020	$20,504.11	$17,410	$384.27	+$60.6K → INZY
6	$111,295	$27,813.68	$19,335	$392.95	+$92.0K → INZY
7	$156,166	$37,080.39	$21,437	$401.10	+$134.7K → INZY
8	$215,724	$48,626.29	$23,733	$408.75	+$192.0K → INZY
9	$293,602	$62,776.77	$26,237	$415.91	+$267.4K → INZY
10	$394,004	$79,849.97	$28,968	$422.61	+$365.0K → INZY

INZY vs SCHD: Complete Analysis 2026

INZY — Stock

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Full INZY Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this INZY vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INZY vs JEPI INZY vs O INZY vs KO INZY vs MAIN INZY vs VYM INZY vs DGRO INZY vs VIG INZY vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.